SmithD.W., FrankelL.R., MathesL.H., AriagnoR.L., ProberC.G.A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.N Engl J Med1991; 325: 24–9.
2.
HallC.B., McBrideJ.T., WalshE.E., BellD.M., GalaC.L.Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection. A randomized double blind study.N Engl J Med1983; 308: 1443–7.
3.
HallC.B., McBrideJ.T., GalaC.L., MildrethS.W., SchnabelK.C.Ribavirin treatment of respiratory syncytial virus infection in infants with underlying cardiopulmonary disease.JAMA1985; 254: 3047–51.
4.
RandolfA.G., WangE.E.Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.Arch Pediatr Adolesc Med1996; 150: 942–7.
5.
McCarthyA.J., BerginM., De SilvaL.M., StevensM.Intravenous ribavirin therapy for disseminated adenovirus infection.Pediatr Inject Dis J1995; 14: 1003–1.
6.
LjungmanP., AnderssonJ., AschanJ.Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogenic bone marrow transplantation.Clin Infect Dis1996; 23: 167–9.
7.
LewinsohnD.M., BowdenR.A., MattsonD., CrawfordS.W.Phase I study of intravenous ribavirin treatment of respiratory syncitial virus pneumonia after marrow transplantation.Antimcrob Ag Chemother1996; 40: 2555–7.
8.
Anonymous.,Multicenter clinical trial of oral ribavirin in symptomatic HIV infected patients. The ribavirin ARC Study Group.J AIDS1993; 6: 32–41.
9.
ConnorE., MorrisonS., LaneJ., OleskeJ., SonkeR.L., ConnerJ.Safety, tolerance and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection.Antimcrob Ag Chemother1993; 37: 532–9.